Triarco says that unpublished preclinical studies and published studies have been done to determine Aminogen’s safety and toxicity guidelines. Moreover, it says, earlier this year Health Canada’s Natural Health Products Directorate cited a clinical study done on Aminogen as being “one of only two studies available to support fungal proteolytic enzyme dosing guidelines.”
